Clene (FRA:84C) FCF Margin % : -4,241.03% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clene FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Clene's Free Cash Flow for the three months ended in Dec. 2023 was €-6.62 Mil. Clene's Revenue for the three months ended in Dec. 2023 was €0.16 Mil. Therefore, Clene's FCF Margin % for the quarter that ended in Dec. 2023 was -4,241.03%.

As of today, Clene's current FCF Yield % is -54.61%.

The historical rank and industry rank for Clene's FCF Margin % or its related term are showing as below:

FRA:84C' s FCF Margin % Range Over the Past 10 Years
Min: -9376.7 Med: -7157.83 Max: -4663.76
Current: -4679.17

During the past 5 years, the highest FCF Margin % of Clene was -4663.76%. The lowest was -9376.70%. And the median was -7157.83%.

FRA:84C's FCF Margin % is ranked worse than
88.14% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs FRA:84C: -4679.17

Clene FCF Margin % Historical Data

The historical data trend for Clene's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene FCF Margin % Chart

Clene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-9,395.27

-4,972.03

-9,332.21

-4,661.67

Clene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-4,022.62	-8,870.00	-2,598.39	-6,315.84	-4,241.03

Competitive Comparison of Clene's FCF Margin %

For the Biotechnology subindustry, Clene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clene's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clene's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Clene's FCF Margin % falls into.

Clene FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Clene's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-27.97	/	0.6
	=	-4,661.67 %

Clene's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-6.616	/	0.156
	=	-4,241.03 %

Clene FCF Margin % Related Terms

Thank you for viewing the detailed overview of Clene's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clene (FRA:84C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (FRA:84C) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CLNN:USA

Address

6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121

Website

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Clene (FRA:84C) Headlines

No Headlines